Abstract
Craniopharyngioma is one of the most challenging brain tumors, located in sellar/suprasellar region in close proximity to the optic apparatus and hypothalamus. Although histologically low grade, the tumor can be locally aggressive and serve as a source of considerable morbidity due to compression and/or adherence to nearby structures. Due to its unpredictable natural history and long-term sequelae of various treatments, the ideal management of craniopharyngioma has been constantly debated over several generations of neurosurgeons. Many clinical series have advocated for gross total resection (GTR) to reduce the risk of tumor recurrence, while craniopharyngiomas are considered unresectable lesions by other authors and a recommendation for a more conservative neurosurgical approach followed by radiation therapy or intracystic treatment is given. The ongoing debate regarding the use of “aggressive” or “less invasive” surgical approaches has at least the benefit of suggesting that treatment plans should be customized to the individual patient and tumor characteristics. In this way, the maximum, safe neurosurgical procedure can be performed while minimizing untoward patient morbidity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alli S, Isik S, Rutka JT (2016) Microsurgical removal of craniopharyngioma: endoscopic and transcranial techniques for complication avoidance. J Neurooncol 130(2):299–307
Apps JR, Martinez-Barbera JP (2016) Molecular pathology of adamantinomatous craniopharyngioma: review and opportunities for practice. Neurosurg Focus 41(6):E4
Balogun JA, Rutka JT (2015) Surgery of craniopharyngiomas in children. In: Kenning TJ, Evans JJ (eds) Craniopharyngiomas. Comprehensive diagnosis, treatment and outcome. Elsevier, New York, pp 459–477
Banna M (1973) Craniopharyngioma in adults. SurgNeurol 1:202–204
Banna M, Hoare RD, Stanley P, Till K (1973) Craniopharyngioma in children. J Pediatr 83(5):781–785
Barkhoudarian G, Laws ER (2013) Craniopharyngioma: history. Pituitary 16:1–8
Bartels S, Adisa A, Aladelusi T, Lemound J, Stucki-Koch A, Hussein S, Kreipe H, Hartmann C, Lehmann U, Hussein K (2018) Molecular defects in BRAF wild-type ameloblastomas and craniopharyngiomas differences in mutation profiles in epithelial-derived oropharyngeal neoplasms. Virchows Arch 472(6):1055–1059. https://doi.org/10.1007/s00428-018-2323-3
Bartels U, Laperriere N, Bouffet E, Drake J (2012) Intracystic therapies for cystic craniopharyngioma in childhood. Front Endocrinol (Lausanne) 3:39
Bernstein JH, Waber DP (1996) Developmental Scoring System for the Rey-Osterrieth Complex Figure. Professional manual. Psychological Assessment Resources, Lutz
Bishop AJ, Greenfield B, Mahajan A, Paulino AC, Okcu MF, Allen PK, Chintagumpala M, Kahalley LS, McAleer MF, McGovern SL, Whitehead WE, Grosshans DR (2014) Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity. Int J Radiat Oncol Biol Phys 90(2):354–361
Brastianos PK, Santagata S (2016) Endocrine tumors: BRAF V600E mutations in papillary craniopharyngioma. Eur J Endocrinol 174(4):R139–R144
Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, Dias-Santagata D, Thorner AR, Lawrence MS, Rodriguez FJ, Bernardo LA, Schubert L, Sunkavalli A, Shillingford N, Calicchio ML, Lidov HG, Taha H, Martinez-Lage M, Santi M, Storm PB, Lee JY, Palmer JN, Adappa ND, Scott RM, Dunn IF, Laws ER Jr, Stewart C, Ligon KL, Hoang MP, Van Hummelen P, Hahn WC, Louis DN, Resnick AC, Kieran MW, Getz G, Santagata S (2014) Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet 46:161–165
Bremer AM, Nguyen TQ, Balsys R (1984) Therapeutic benefits of combination chemotherapy with vincristine, BCNU, and procarbazine on recurrent cystic craniopharyngioma. I Ncuroomol 2:47–51
Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM (1998) The descriptive epidemiology of craniopharyngioma. J Neurosurg 89(4):547–551
Carmel PW, Antunes JL, Chang CH (1982) Craniopharyngiomas in children. Neurosurgery 11:382–389
Carpentieri SC, Waber DP, Scott RM, Goumnerova LC, Kieran MW, Cohen LE, Kim F, Billett AL, Tarbell NJ, Pomeroy SL (2001) Memory deficits among children with craniopharyngiomas. Neurosurgery 49(5):1053–1057
Cavalheiro S, Di Rocco C, Valenzuela S, Dastoli PA, Tamburrini G, Massimi L, Nicacio JM, Faquini IV, Ierardi DF, Silva NS, Pettorini BL, Toledo SR (2010) Craniopharyngiomas: intratumoral chemotherapy with interferon-α: a multicenter preliminary study with 60 cases. Neurosurg Focus 28(4):E1
Chen M, Zheng SH, Yang M, Chen ZH, Li ST (2018) The diagnostic value of preoperative inflammatory markers in craniopharyngioma: a multicenter cohort study. J Neurooncol 138(1):113–122. https://doi.org/10.1007/s11060-018-2776-x.
Cohen M, Bartels U, Branson H, Kulkarni AV, Hamilton J (2013) Trends in treatment and outcomes of pediatric craniopharyngioma, 1975-2011. Neuro Oncol 15(6):767–774
Cook DJ, Rutka JT (2009) Craniopharyngiomas: neurosurgical management. In: Hanna YE, DeMonte F (eds) Comprehensive management of skull base tumors. Informa Healthcare, New York, pp 573–581
Coy S, Rashid R, Lin JR, Du Z, Donson AM, Hankinson TC, Foreman NK, Manley PE, Kieran MW, Reardon DA, Sorger PK, Santagata S (2018) Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma. Neuro Oncol 20(8):1101–1112. https://doi.org/10.1093/neuonc/noy035
Crotty TB, Scheithauer BW, Young WF Jr, Davis DH, Shaw EG, Miller GM, Burger PC (1995) Papillary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg 83:206–214
Crowley RK (2011) Hypothalamic disease in craniopharyngioma patients [MD Thesis]. Royal College of Surgeons in Ireland, Dublin
Defoort-Dhellemmes S, Moritz F, Bouacha I, Vinchon M (2006) Craniopharyngioma: ophthalmological aspects at diagnosis. J Pediatr Endocrinol Metab JPEM 19(Suppl 1):321–324
Derrey S, Blond S, Reyns N, Touzet G, Carpentier P, Gauthier H, Dhellemmes P (2008) Management of cystic craniopharyngiomas with stereotactic endocavitary irradiation using colloidal 186Re: a retrospective study of 48 consecutive patients. Neurosurgery 63:1045–1053
Desai KI, Nadkarni TD, Muzumdar DP, Goel AH (2002) Surgical management of colloid cyst of the third ventricle—a study of 105 cases. Surg Neurol 57:295–302
Drimtzias E, Falzon K, Picton S, Jeeva I, Guy D, Nelson O, Simmons I (2014) The ophthalmic natural history of paediatric craniopharyngioma: a long-term review. J Neurooncol 120(3):651–656
Elliott RE, Sands SA, Strom RG, Wisoff JH (2010) Craniopharyngioma Clinical Status Scale: a standardized metric of preoperative function and posttreatment outcome. Neurosurg Focus 28:E2
Erdheim J (1904) Uber hypophysenganggeschwwuste und hirncholesteatome. Gerold, Wien
Fitzek MM, Linggood RM, Adams J, Munzenrider JE (2006) Combined proton and photon irradiation for craniopharyngioma: long-term results of the early cohort of patients treated at Harvard Cyclotron Laboratory and Massachusetts General Hospital. Int J Radiat Oncol Biol Phys 64:1348–1354
Fjalldal S, Follin C, Svärd D, Rylander L, Gabery S, Petersen Å, Van Westen D, Sundgren P, Bjorkman-Burtscher I, Lätt J, Ekman B, Johanson A, Erfurth EM (2018) Microstructural white matter alterations and hippocampal volumes are associated with cognitive deficits in craniopharyngioma. Eur J Endocrinol 178(6):577–587. https://doi.org/10.1530/EJE-18-0081
Fjalldal S, Holmer H, Rylander L, Elfving M, Ekman B, Osterberg K, Erfurth EM (2013) Hypothalamic involvement predicts cognitive performance and psychosocial health in long-term survivors of childhood craniopharyngioma. J Clin Endocrinol Metabol 98(8):3253–3262
Gerganov V, Metwali H, Samii A, Fahlbusch R, Samii M (2014) Microsurgical resection of extensive craniopharyngiomas using a frontolateral approach: operative technique and outcome. J Neurosurg 120:559–570
Golshani KJ, Lalwani K, Delashaw JB, Selden NR (2009) Modified orbitozygomatic craniotomy for craniopharyngioma resection in children. J Neurosurg Pediatr 4:345–352
Gong J, Zhang H, Xing S, Li C, Ma Z, Jia G, Hu W (2014) High expression levels of CXCL12 and CXCR4 predict recurrence of adamanti-nomatous craniopharyngiomas in children. Cancer Biomark 14(4):241–251
González Briceño L, Grill J, Bourdeaut F, Doz F, Beltrand J, Benabbad I, Brugières L, Dufour C, Valteau-Couanet D, Guerrini-Rousseau L, Aerts I, Orbach D, Alapetite C, Samara-Boustani D, Pinto G, Simon A, Touraine P, Sainte-Rose C, Zerah M, Puget S, Elie C, Polak M (2014) Water and electrolyte disorders at long-term post-treatment follow-up in paediatric patients with suprasellar tumours include unexpected persistent cerebral salt-wasting syndrome. Horm Res Paediatr 82(6):364–371
Graffeo CS, Perry A, Link MJ, Daniels DJ (2018) Pediatric craniopharyngiomas: a primer for the skull base surgeon. J Neurol Surg B 79(1):65–80
Greenfield BJ, Okcu MF, Baxter PA, Chintagumpala M, Teh BS, Dauser RC, Su J, Desai SS, Paulino AC (2015) Long-term disease control and toxicity outcomes following surgery and intensity modulated radiation therapy (IMRT) in pediatric craniopharyngioma. Radiother Oncol 114(2):224–229
Hadad G, Bassagasteguy L, Carrau RL, Mataza JC, Kassam A, Snyderman CH, Mintz A (2006) A novel reconstructive technique after endoscopic expanded endonasal approaches: vascular pedicle nasoseptal flap. Laryngoscope 116:1882–1886
Halac I, Zimmerman D (2005) Endocrine manifestations of craniopharyngioma. Childs Nerv Syst 21(8–9):640–648
Hirsch O (1912) Die operative behandlung von hypophysistumoren: Nach endonasalen methoden. Arch Laryngol Rhinol 26:529–686
Hoffmann A, Bootsveld K, Gebhardt U, Daubenbuchel AM, Sterkenburg AS, Muller HL (2015) Nonalcoholic fatty liver disease and fatigue in long-term survivors of childhood-onset craniopharyngioma. Eur J Endocrinol 173(3):389–397
Hopper N, Albanese A, Ghirardello S, Maghnie M (2006) The pre-operative endocrine assessment of craniopharyngiomas. JPEM 19(Suppl 1):325–327
Jastak S (1990) Wide range assessment of memory and learning. Adams and Sheslow, New York
Kaplan E, Goodglass H, Weintraub S (1983) Boston naming test. Lea & Febiger, Philadelphia
Karavitaki N, Brufani C, Warner JT, Adams CB, Richards P, Ansorge O, Shine B, Turner HE, Wass JA (2005) Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 62(4):397–409
Kassam AB, Gardner PA, Snyderman CH, Carrau RL, Mintz AH, Prevedello DM (2008) Expanded endonasal approach, a fully endoscopic transnasal approach for the resection of midline suprasellar craniopharyngiomas: a new classification based on the infundibulum. J Neurosurg 108:715–728
Klimo P Jr, Venable GT, Boop FA, Merchant T (2015) Recurrent craniopharyngioma after conformal radiation in children and the burden of treatment. J Neurosurg Pediatr 15:499–505
Lafay-Cousin L, Bartels U, Raybaud C, Kulkarni AV, Guger S, Huang A, Bouffet E (2007) Neuroradiological findings of bleomycin leakage in cystic craniopharyngioma. J Neurosurg 107(4 Suppl):318–323
Lamiman K, Wong KK, Tamrazi B, Nosrati JD, Olch A, Chang EL, Kiehna EN (2016) A quantitative analysis of craniopharyngioma cyst expansion during and after radiation therapy and surgical implications. Neurosurg Focus 41(6):E15
Leber KA, Berglöff J, Pendl G (1998) Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 88:43–50
Lee YY, Wong TT, Fang YT, Chang KP, Chen YW, Niu DM (2008) Comparison of hypothalamopituitary axis dysfunction of intrasellar and third ventricular craniopharyngiomas in children. Brain Dev 30(3):189–194
Lehrnbecher T, Muller-Scholden J, Danhauser-Leistner I, Sorensen N, von Stockhausen HB (1998) Perioperative fluid and electrolyte management in children undergoing surgery for craniopharyngioma. A 10-year experience in a single institution. Childs Nerv Syst 14(6):276–279
Lippens RJ, Rotteveel JJ, Otten BJ, Merx H (1998) Chemotherapy with Adriamycin@ (doxorubicin) and CCNU@ (lomustine) in four children with recurrent craniopharyngiomaEur. J Paediatr Neurol 2(5):263–268
Liu JK, Christiano LD, Gupta G, Carmel PW (2010) Surgical nuances for removal of retrochiasmatic craniopharyngiomas via the transbasal subfrontal translamina terminalis approach. Neurosurg Focus 28:E6
Iughetti L, Bruzzi P (2011) Obesity and craniopharyngioma. Ital J Pediatr 16(37):38
Luu QT, Loredo LN, Archambeau JO, Yonemoto LT, Slater JM, Slater JD (2006) Fractionated proton radiation treatment for pediatric craniopharyngioma: preliminary report. Cancer J 12:155–159
Martinez-Gutierrez JC, D’Andrea MR, Cahill DP, Santagata S, Barker FG 2nd, Brastianos PK (2016) Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapy. Neurosurg Focus 41(6):E2
Miller DC (1994) Pathology of craniopharyngiomas: clinical import of pathological findings. Pediatr Neurosurg 21(Suppl 1):11–17
Minniti G, Saran F, Traish D, Soomal R, Sardell S, Gonsalves A, Ashley S, Warrington J, Burke K, Mosleh-Shirazi A, Brada M (2007) Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas. Radiother Oncol 82:90–95
Morisako H, Goto T, Goto H, Bohoun CA, Tamrakar S, Ohata K (2016) Aggressive surgery based on an anatomical subclassification of craniopharyngiomas. Neurosurg Focus 41(6):E10
Müller HL (2016) Risk-adapted treatment and followup management in childhood-onset craniopharyngioma. Expert Rev Neurother 16(5):535–548
Muller HL (2008) Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up. Horm Res 69:193–202
Muller HL (2016) Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity. Curr Opin Endocrinol Diabetes Obes 23(1):81–89
Murphy MJ, Chang SD, Gibbs IC, Le QT, Hai J, Kim D, Martin DP, Adler JR Jr (2003) Patterns of patient movement during frameless image-guided radiosurgery. Int J Radiat Oncol Biol Phys 55:1400–1408
Nielsen EH, Feldt-Rasmussen U, Poulsgaard L, Kristensen LO, Astrup J, Jorgensen JO, Bjerre P, Andersen M, Andersen C, Jorgensen J, Lindholm J, Laurberg P (2011) Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults. J Neurooncol 104:755–763
Pettorini BL, Inzitari R, Massimi L, Tamburrini G, Caldarelli M, Fanali C, Cabras T, Messana I, Castagnola M, Di Rocco C (2010) The role of inflammation in the genesis of the cystic component of craniopharyngiomas. Childs Nerv Syst 26(12):1779–1784
Poretti A, Grotzer MA, Ribi K, Schonle E, Boltshauser E (2004) Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev Med Child Neurol 46:220–229
Prabhu VC, Brown HG (2005) The pathogenesis of craniopharyngiomas. Childs Nerv Syst 21(8–9):622–627
Prieto R, Pascual JM, Rosdolsky M, Barrios L (2018) Preoperative assessment of craniopharyngioma adherence: magnetic resonance imaging findings correlated with the severity of tumor attachment to the hypothalamus. World Neurosurg 110:e404–e426
Puget S, Garnett M, Wray A, Grill J, Habrand JL, Bodaert N, Zerah M, Bezerra M, Renier D, Pierre-Kahn A, Sainte-Rose C (2007) Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg 106(1 Suppl):3–12
Rhoton AL Jr (2002) The sellar region. Neurosurgery 51(4 Suppl):S335–S374
Rhoton AL Jr (2001) Anatomy of the pituitary gland and sellar region. In: Thapar K, Kovacs K, Scheithauer BW, Lloyd RV (eds) Diagnosis and management of pituitary tumors. Humana Press, Totowa
Robinson AG, Verbalis JG (2003) Posterior pituitary gland. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (eds) Williams textbook of endocrinology. Elsevier, Philadelphia, pp 281–329
Rosenfeld A, Arrington D, Miller J, Olson M, Gieseking A, Etzl M, Harel B, Schembri A, Kaplan A (2014) A review of childhood and adolescent craniopharyngiomas with particular attention to hypothalamic obesity. Pediatr Neurol 50(1):4–10
Rutka JT (2002) Craniopharyngioma. J Neurosurg 97:1–2
Rutka JT, Hoffman HJ, Drake JM, Humphreys RP (1992) Suprasellar and sellar tumors in childhood and adolescence. Neurosurg Clin N Am 3:803–820
Schiebler TH, Schmidt W, Zilles K (1995) Anatomie. Springer, Berlin
Sekine S, Takata T, Shibata T, Mori M, Morishita Y, Noguchi M, Uchida T, Kanai Y, Hirohashi S (2004) Expression of enamel proteins and LEF1 in adamantinomatous craniopharyngioma: evidence for its odontogenic epithelial differentiation. Histopathology 45:573–579
Shi XE, Wu B, Fan T, Zhou ZQ, Zhang YL (2008) Craniopharyngioma: surgical experience of 309 cases in China. Clin Neurol Neurosurg 110:151–159
Shoemaker A, Proietto J, Abuzzahab MJ, Markovic T, Malloy J, Kim DD (2017) A randomized, placebo-controlled trial of beloranib for the treatment of hypothalamic injury-associated obesity. Diabetes Obes Metab 19(8):1165–1170
Sorva R (1988) Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain. Acta Paediatr Scand 77(4):587–592
Stark KL, Kaufman B, Lee BC, Primack J, Tychsen L (1999) Visual recovery after a year of craniopharyngioma-related amaurosis: report of a nine-year-old child and a review of pathophysiologic mechanisms. JAAPOS 3:366–371
Tomita T, McLone DG (1993) Radical resections of childhood craniopharyngiomas. Pediatr Neurosurg 19(1):6–14
Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM (2001) Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357(9254):425–431
Van Effenterre R, Boch AL (2002) Craniopharyngioma in adults and children: a study of 122 surgical cases. J Neurosurg 97:3–11
Vaquero J, Zurita M, de Oya S, Coca S, Morales C, Salas C (1999) Expression of vascular permeability factor in craniopharyngioma. J Neurosurg 91:831–834
Veeravagu A, Lee M, Jiang B, Chang SD (2010) The role of radiosurgery in the treatment of craniopharyngiom. Neurosurg Focus 28(4):E11
Voges J, Sturm V, Lehrke R, Treuer H, Gauss C, Berthold F (1997) Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal betaemitting radioactive sources. Neurosurgery 40:263–270
Wang F, Jiang J, Zhang J, Wang Q (2017) Predicting pituitary stalk position by in vivo visualization of the hypothalamo-hypophyseal tract in craniopharyngioma using diffusion tensor imaging tractography. Neurosurg Rev 41(3):841–849. https://doi.org/10.1007/s10143-017-0933-x.
Wechsler D (1991) WISC-III: Wechsler Intelligence Scale for children, 3rd edn. Psychological Corp, San Antonio
Weiner HL, Wisoff JH, Rosenberg ME, Kupersmith MJ, Cohen H, Zagzag D, Shiminski-Maher T, Flamm ES, Epstein FJ, Miller DC (1994) Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery 35:1001–1010
Yasargil MG, Curcic M, Kis M, Siegenthaler G, Teddy PJ, Roth P (1990) Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J Neurosurg 73(1):3–11
Zitvogel L, Galluzzi L, Kepp O, Smyth MJ, Kroemer G (2015) Type I interferons in anticancer immunity. Nat Rev Immunol 15(7):405–414
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Habibi, Z., Reesh, D.A., Rutka, J.T. (2019). Craniopharyngioma: Current Classification, Management, and Future Directions. In: Tonn, JC., Reardon, D., Rutka, J., Westphal, M. (eds) Oncology of CNS Tumors. Springer, Cham. https://doi.org/10.1007/978-3-030-04152-6_30
Download citation
DOI: https://doi.org/10.1007/978-3-030-04152-6_30
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-04151-9
Online ISBN: 978-3-030-04152-6
eBook Packages: MedicineMedicine (R0)